SUPRENZA Drug Patent Profile
✉ Email this page to a colleague
When do Suprenza patents expire, and what generic alternatives are available?
Suprenza is a drug marketed by Citius Pharms and is included in one NDA. There is one patent protecting this drug and two Paragraph IV challenges.
This drug has two patent family members in two countries.
The generic ingredient in SUPRENZA is phentermine hydrochloride. There are seventeen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the phentermine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Suprenza
A generic version of SUPRENZA was approved as phentermine hydrochloride by ELITE LABS INC on May 30th, 1997.
Summary for SUPRENZA
International Patents: | 2 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 44 |
Patent Applications: | 909 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for SUPRENZA |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for SUPRENZA |
DailyMed Link: | SUPRENZA at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for SUPRENZA
Paragraph IV (Patent) Challenges for SUPRENZA
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
SUPRENZA | Orally Disintegrating Tablets | phentermine hydrochloride | 37.5 mg | 202088 | 1 | 2013-03-22 |
SUPRENZA | Orally Disintegrating Tablets | phentermine hydrochloride | 15 mg and 30 mg | 202088 | 1 | 2012-10-19 |
US Patents and Regulatory Information for SUPRENZA
SUPRENZA is protected by one US patents.
Patents protecting SUPRENZA
Orally disintegrating tablets with speckled appearance
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Citius Pharms | SUPRENZA | phentermine hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 202088-001 | Jun 13, 2011 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Citius Pharms | SUPRENZA | phentermine hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 202088-002 | Jun 13, 2011 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Citius Pharms | SUPRENZA | phentermine hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 202088-003 | Mar 27, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SUPRENZA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Citius Pharms | SUPRENZA | phentermine hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 202088-001 | Jun 13, 2011 | ⤷ Try a Trial | ⤷ Try a Trial |
Citius Pharms | SUPRENZA | phentermine hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 202088-002 | Jun 13, 2011 | ⤷ Try a Trial | ⤷ Try a Trial |
Citius Pharms | SUPRENZA | phentermine hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 202088-003 | Mar 27, 2012 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for SUPRENZA
See the table below for patents covering SUPRENZA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 2263216 | ⤷ Try a Trial | |
European Patent Office | 1001748 | PROCEDE DE PREPARATION DE GRANULES SERVANT A PRODUIRE DES COMPRIMES SOLUBLES DANS LA BOUCHE A DESINTEGRATION RAPIDE (A PROCESS FOR THE PREPARATION OF A GRANULATE SUITABLE TO THE PREPARATION OF RAPIDLY DISINTEGRABLE MOUTH-SOLUBLE TABLETS) | ⤷ Try a Trial |
Japan | 2001510785 | ⤷ Try a Trial | |
Australia | 8977698 | ⤷ Try a Trial | |
Japan | 4947833 | ⤷ Try a Trial | |
World Intellectual Property Organization (WIPO) | 9904758 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for SUPRENZA
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2317997 | 2190050-1 | Sweden | ⤷ Try a Trial | PRODUCT NAME: PHENTERMINE AND TOPIRAMATE; NAT. REG. NO/DATE: 59574-59577 20210617; FIRST REG.: IS IS/1/21/018/01-04 20210212 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |